CXCL12 and neoplasm: The binding of the canonical CXCR4 ligand CXCL12 (SDF1) promotes tumour cell proliferation, survival, and metastasis, with the CXCR4+ tumour cells having a high self-renewal capacity and potent tumorigencity [25,64,65,66].